How does Keytruda work?
Information reviewed July 24, 2026
Keytruda is a PD-1 checkpoint inhibitor. Many cancers evade the immune system by activating the PD-1 pathway. Keytruda blocks this pathway, allowing immune T-cells to recognize and destroy cancer cells.
More about Keytruda
More questions about Keytruda
Reference only
This information is for general reference and is not medical advice. Always consult a licensed healthcare professional about your treatment.